Logo image of GBT.PA

GUERBET (GBT.PA) Stock Fundamental Analysis

Europe - EPA:GBT - FR0000032526 - Common Stock

14.58 EUR
+0.3 (+2.1%)
Last: 10/17/2025, 7:00:00 PM
Fundamental Rating

4

Overall GBT gets a fundamental rating of 4 out of 10. We evaluated GBT against 63 industry peers in the Health Care Equipment & Supplies industry. The financial health of GBT is average, but there are quite some concerns on its profitability. GBT has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year GBT was profitable.
GBT had a positive operating cash flow in the past year.
GBT had positive earnings in 4 of the past 5 years.
GBT had a positive operating cash flow in each of the past 5 years.
GBT.PA Yearly Net Income VS EBIT VS OCF VS FCFGBT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

With a Return On Assets value of 0.76%, GBT is not doing good in the industry: 60.32% of the companies in the same industry are doing better.
With a Return On Equity value of 2.06%, GBT is not doing good in the industry: 60.32% of the companies in the same industry are doing better.
GBT has a worse Return On Invested Capital (3.17%) than 65.08% of its industry peers.
The Average Return On Invested Capital over the past 3 years for GBT is significantly below the industry average of 9.52%.
Industry RankSector Rank
ROA 0.76%
ROE 2.06%
ROIC 3.17%
ROA(3y)-0.17%
ROA(5y)0.94%
ROE(3y)-0.15%
ROE(5y)2.51%
ROIC(3y)4.08%
ROIC(5y)3.99%
GBT.PA Yearly ROA, ROE, ROICGBT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

Looking at the Profit Margin, with a value of 0.96%, GBT is doing worse than 61.90% of the companies in the same industry.
In the last couple of years the Profit Margin of GBT has declined.
GBT has a Operating Margin of 4.23%. This is in the lower half of the industry: GBT underperforms 65.08% of its industry peers.
In the last couple of years the Operating Margin of GBT has declined.
The Gross Margin of GBT (78.03%) is better than 90.48% of its industry peers.
In the last couple of years the Gross Margin of GBT has remained more or less at the same level.
Industry RankSector Rank
OM 4.23%
PM (TTM) 0.96%
GM 78.03%
OM growth 3Y2.51%
OM growth 5Y-2.16%
PM growth 3Y-24.58%
PM growth 5Y-15.99%
GM growth 3Y1.72%
GM growth 5Y0.58%
GBT.PA Yearly Profit, Operating, Gross MarginsGBT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), GBT is destroying value.
Compared to 1 year ago, GBT has about the same amount of shares outstanding.
GBT has more shares outstanding than it did 5 years ago.
The debt/assets ratio for GBT is higher compared to a year ago.
GBT.PA Yearly Shares OutstandingGBT.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
GBT.PA Yearly Total Debt VS Total AssetsGBT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 2.06 indicates that GBT is not a great score, but indicates only limited risk for bankruptcy at the moment.
GBT has a Altman-Z score (2.06) which is in line with its industry peers.
GBT has a debt to FCF ratio of 8.88. This is a slightly negative value and a sign of low solvency as GBT would need 8.88 years to pay back of all of its debts.
GBT has a Debt to FCF ratio (8.88) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.93 indicates that GBT is somewhat dependend on debt financing.
GBT's Debt to Equity ratio of 0.93 is on the low side compared to the rest of the industry. GBT is outperformed by 79.37% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 8.88
Altman-Z 2.06
ROIC/WACC0.46
WACC6.95%
GBT.PA Yearly LT Debt VS Equity VS FCFGBT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

GBT has a Current Ratio of 2.32. This indicates that GBT is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.32, GBT is in the better half of the industry, outperforming 69.84% of the companies in the same industry.
A Quick Ratio of 1.03 indicates that GBT should not have too much problems paying its short term obligations.
GBT has a Quick ratio (1.03) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.32
Quick Ratio 1.03
GBT.PA Yearly Current Assets VS Current LiabilitesGBT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

3

3. Growth

3.1 Past

The earnings per share for GBT have decreased strongly by -76.89% in the last year.
The earnings per share for GBT have been decreasing by -15.50% on average. This is quite bad
The Revenue has decreased by -2.01% in the past year.
The Revenue has been growing slightly by 0.59% on average over the past years.
EPS 1Y (TTM)-76.89%
EPS 3Y-21.06%
EPS 5Y-15.5%
EPS Q2Q%-75.86%
Revenue 1Y (TTM)-2.01%
Revenue growth 3Y4.74%
Revenue growth 5Y0.59%
Sales Q2Q%-7.5%

3.2 Future

Based on estimates for the next years, GBT will show a decrease in Earnings Per Share. The EPS will decrease by -6.01% on average per year.
GBT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.37% yearly.
EPS Next Y-70.82%
EPS Next 2Y-22.44%
EPS Next 3Y-12.67%
EPS Next 5Y-6.01%
Revenue Next Year-3.65%
Revenue Next 2Y-0.26%
Revenue Next 3Y1.17%
Revenue Next 5Y3.37%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
GBT.PA Yearly Revenue VS EstimatesGBT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M
GBT.PA Yearly EPS VS EstimatesGBT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 23.90, which indicates a rather expensive current valuation of GBT.
Based on the Price/Earnings ratio, GBT is valued a bit cheaper than the industry average as 76.19% of the companies are valued more expensively.
GBT is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.40, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 9.42, which indicates a very decent valuation of GBT.
GBT's Price/Forward Earnings ratio is rather cheap when compared to the industry. GBT is cheaper than 92.06% of the companies in the same industry.
GBT is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.94, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 23.9
Fwd PE 9.42
GBT.PA Price Earnings VS Forward Price EarningsGBT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of GBT indicates a rather cheap valuation: GBT is cheaper than 93.65% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, GBT is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 4.11
EV/EBITDA 3.96
GBT.PA Per share dataGBT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

A cheap valuation may be justified as GBT's earnings are expected to decrease with -12.67% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-22.44%
EPS Next 3Y-12.67%

3

5. Dividend

5.1 Amount

GBT has a Yearly Dividend Yield of 2.69%.
In the last 3 months the price of GBT has falen by -32.50%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
Compared to an average industry Dividend Yield of 2.10, GBT pays a better dividend. On top of this GBT pays more dividend than 90.48% of the companies listed in the same industry.
GBT's Dividend Yield is comparable with the S&P500 average which is at 2.36.
Industry RankSector Rank
Dividend Yield 2.69%

5.2 History

The dividend of GBT decreases each year by -10.05%.
Dividend Growth(5Y)-10.05%
Div Incr Years0
Div Non Decr Years1
GBT.PA Yearly Dividends per shareGBT.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6 0.8

5.3 Sustainability

81.48% of the earnings are spent on dividend by GBT. This is not a sustainable payout ratio.
The Dividend Rate of GBT has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP81.48%
EPS Next 2Y-22.44%
EPS Next 3Y-12.67%
GBT.PA Yearly Income VS Free CF VS DividendGBT.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M
GBT.PA Dividend Payout.GBT.PA Dividend Payout, showing the Payout Ratio.GBT.PA Dividend Payout.PayoutRetained Earnings

GUERBET

EPA:GBT (10/17/2025, 7:00:00 PM)

14.58

+0.3 (+2.1%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)09-24 2025-09-24
Earnings (Next)10-23 2025-10-23
Inst Owners15.78%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap184.29M
Analysts46
Price Target18.61 (27.64%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.69%
Yearly Dividend0.5
Dividend Growth(5Y)-10.05%
DP81.48%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-30.48%
PT rev (3m)-33.03%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-60.62%
EPS NY rev (3m)-70.33%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-5.99%
Revenue NY rev (3m)-6.03%
Valuation
Industry RankSector Rank
PE 23.9
Fwd PE 9.42
P/S 0.23
P/FCF 4.11
P/OCF 1.97
P/B 0.49
P/tB 0.67
EV/EBITDA 3.96
EPS(TTM)0.61
EY4.18%
EPS(NY)1.55
Fwd EY10.62%
FCF(TTM)3.55
FCFY24.35%
OCF(TTM)7.41
OCFY50.79%
SpS64.06
BVpS29.76
TBVpS21.75
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.76%
ROE 2.06%
ROCE 4.49%
ROIC 3.17%
ROICexc 3.67%
ROICexgc 4.33%
OM 4.23%
PM (TTM) 0.96%
GM 78.03%
FCFM 5.54%
ROA(3y)-0.17%
ROA(5y)0.94%
ROE(3y)-0.15%
ROE(5y)2.51%
ROIC(3y)4.08%
ROIC(5y)3.99%
ROICexc(3y)4.61%
ROICexc(5y)4.69%
ROICexgc(3y)5.43%
ROICexgc(5y)6.06%
ROCE(3y)5.76%
ROCE(5y)5.64%
ROICexcg growth 3Y-4.82%
ROICexcg growth 5Y-5.63%
ROICexc growth 3Y2.13%
ROICexc growth 5Y-2.41%
OM growth 3Y2.51%
OM growth 5Y-2.16%
PM growth 3Y-24.58%
PM growth 5Y-15.99%
GM growth 3Y1.72%
GM growth 5Y0.58%
F-Score5
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 8.88
Debt/EBITDA 3.26
Cap/Depr 66.32%
Cap/Sales 6.02%
Interest Coverage 1.61
Cash Conversion 86.9%
Profit Quality 580.05%
Current Ratio 2.32
Quick Ratio 1.03
Altman-Z 2.06
F-Score5
WACC6.95%
ROIC/WACC0.46
Cap/Depr(3y)72.12%
Cap/Depr(5y)80.72%
Cap/Sales(3y)6.9%
Cap/Sales(5y)7.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-76.89%
EPS 3Y-21.06%
EPS 5Y-15.5%
EPS Q2Q%-75.86%
EPS Next Y-70.82%
EPS Next 2Y-22.44%
EPS Next 3Y-12.67%
EPS Next 5Y-6.01%
Revenue 1Y (TTM)-2.01%
Revenue growth 3Y4.74%
Revenue growth 5Y0.59%
Sales Q2Q%-7.5%
Revenue Next Year-3.65%
Revenue Next 2Y-0.26%
Revenue Next 3Y1.17%
Revenue Next 5Y3.37%
EBIT growth 1Y-41.57%
EBIT growth 3Y7.37%
EBIT growth 5Y-1.59%
EBIT Next Year61.5%
EBIT Next 3Y25.44%
EBIT Next 5Y21.2%
FCF growth 1Y183.49%
FCF growth 3Y-28.77%
FCF growth 5Y-19.52%
OCF growth 1Y2774.75%
OCF growth 3Y-11.2%
OCF growth 5Y-9.16%